276 related articles for article (PubMed ID: 27107921)
1. Home Treatment of Pulmonary Embolism in the Era of Novel Oral Anticoagulants.
Stein PD; Matta F; Hughes PG; Hourmouzis ZN; Hourmouzis NP; White RM; Ghiardi MM; Schwartz MA; Moore HL; Bach JA; Schweiss RE; Kazan VM; Kakish EJ; Keyes DC; Hughes MJ
Am J Med; 2016 Sep; 129(9):974-7. PubMed ID: 27107921
[TBL] [Abstract][Full Text] [Related]
2. Expanding eligibility for outpatient treatment of deep venous thrombosis and pulmonary embolism with low-molecular-weight heparin: a comparison of patient self-injection with homecare injection.
Wells PS; Kovacs MJ; Bormanis J; Forgie MA; Goudie D; Morrow B; Kovacs J
Arch Intern Med; 1998 Sep; 158(16):1809-12. PubMed ID: 9738611
[TBL] [Abstract][Full Text] [Related]
3. Home treatment of deep venous thrombosis in the era of new oral anticoagulants.
Stein PD; Matta F; Hughes PG; Ghiardi M; Marsh JH; Khwarg J; Brandon MS; Fowkes HA; Kazan V; Wiepking M; Keyes DC; Kakish EJ; Hughes MJ
Clin Appl Thromb Hemost; 2015 Nov; 21(8):729-32. PubMed ID: 26239315
[TBL] [Abstract][Full Text] [Related]
4. Rivaroxaban versus Heparin Bridging to Warfarin Therapy: Impact on Hospital Length of Stay and Treatment Costs for Low-Risk Patients with Pulmonary Embolism.
Weeda ER; Kohn CG; Peacock WF; Fermann GJ; Crivera C; Schein JR; Coleman CI
Pharmacotherapy; 2016 Oct; 36(10):1109-1115. PubMed ID: 27548074
[TBL] [Abstract][Full Text] [Related]
5. Community-based treatment of venous thromboembolism with a low-molecular-weight heparin and warfarin.
Hyers TM; Spyropoulos AC;
J Thromb Thrombolysis; 2007 Dec; 24(3):225-32. PubMed ID: 17334932
[TBL] [Abstract][Full Text] [Related]
6. Outpatient treatment of pulmonary embolism with dalteparin.
Kovacs MJ; Anderson D; Morrow B; Gray L; Touchie D; Wells PS
Thromb Haemost; 2000 Feb; 83(2):209-11. PubMed ID: 10739374
[TBL] [Abstract][Full Text] [Related]
7. Outpatient treatment of pulmonary embolism: A single center 4-year experience.
Huyler A; MacVane CZ; Strout T; Perron AD
Am J Emerg Med; 2021 Jul; 45():169-172. PubMed ID: 33041137
[TBL] [Abstract][Full Text] [Related]
8. Economic and utilization outcomes associated with choice of treatment for venous thromboembolism in hospitalized patients.
Knight KK; Wong J; Hauch O; Wygant G; Aguilar D; Ofman JJ
Value Health; 2005; 8(3):191-200. PubMed ID: 15877591
[TBL] [Abstract][Full Text] [Related]
9. Anticoagulation for venous thromboembolism. What are the current options?
Yacovella T; Alter M
Postgrad Med; 2000 Sep; 108(4):43-6, 51-4. PubMed ID: 11021258
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of a pharmacist-managed inpatient anticoagulation service for warfarin initiation and titration.
Wong YM; Quek YN; Tay JC; Chadachan V; Lee HK
J Clin Pharm Ther; 2011 Oct; 36(5):585-91. PubMed ID: 21070296
[TBL] [Abstract][Full Text] [Related]
11. Possible failure of novel direct-acting oral anticoagulants in management of pulmonary embolism: a case report.
Rankin J; Nagar M; Crosby J; Toomari N; Pietras R; Ben-Zur UM
J Med Case Rep; 2016 Dec; 10(1):346. PubMed ID: 27912791
[TBL] [Abstract][Full Text] [Related]
12. Update on pharmacologic therapy for pulmonary embolism.
Harikrishnan P; Palaniswamy C; Aronow WS
J Cardiovasc Pharmacol Ther; 2014 Mar; 19(2):159-69. PubMed ID: 24177334
[TBL] [Abstract][Full Text] [Related]
13. Outpatient management of anticoagulation therapy.
du Breuil AL; Umland EM
Am Fam Physician; 2007 Apr; 75(7):1031-42. PubMed ID: 17427618
[TBL] [Abstract][Full Text] [Related]
14. Best Clinical Practice: Controversies in Outpatient Management of Acute Pulmonary Embolism.
Long B; Koyfman A
J Emerg Med; 2017 May; 52(5):668-679. PubMed ID: 28007362
[TBL] [Abstract][Full Text] [Related]
15. Early, real-world experience with direct oral anticoagulants in the treatment of intermediate-high risk acute pulmonary embolism.
Santos SM; Cunha S; Baptista R; Monteiro S; Monteiro P; Gonçalves F; Pêgo M
Rev Port Cardiol; 2017 Nov; 36(11):801-806. PubMed ID: 29126891
[TBL] [Abstract][Full Text] [Related]
16. Ximelagatran vs low-molecular-weight heparin and warfarin for the treatment of deep vein thrombosis: a randomized trial.
Fiessinger JN; Huisman MV; Davidson BL; Bounameaux H; Francis CW; Eriksson H; Lundström T; Berkowitz SD; Nyström P; Thorsén M; Ginsberg JS;
JAMA; 2005 Feb; 293(6):681-9. PubMed ID: 15701909
[TBL] [Abstract][Full Text] [Related]
17. Out of hospital anticoagulant therapy in patients with acute pulmonary embolism is frequently practised but not perfect.
van Bladel ER; Agterof MJ; Frijling BD; van der Griend R; Prins MH; Schutgens RE; Biesma DH
Thromb Res; 2010 Dec; 126(6):481-5. PubMed ID: 20888623
[TBL] [Abstract][Full Text] [Related]
18. Treatment of venous thromboembolism: adherence to guidelines and impact of physician knowledge, attitudes, and beliefs.
Caprini JA; Tapson VF; Hyers TM; Waldo AL; Wittkowsky AK; Friedman R; Colgan KJ; Shillington AC;
J Vasc Surg; 2005 Oct; 42(4):726-33. PubMed ID: 16242561
[TBL] [Abstract][Full Text] [Related]
19. Shorter Hospital Stays and Lower Costs for Rivaroxaban Compared With Warfarin for Venous Thrombosis Admissions.
Margolis JM; Deitelzweig S; Kline J; Tran O; Smith DM; Bookhart B; Crivera C; Schein J
J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27792638
[TBL] [Abstract][Full Text] [Related]
20. Early discharge of patients with venous thromboembolism: implications regarding therapy.
Stein PD; Hull RD; Matta F; Yaekoub AY
Clin Appl Thromb Hemost; 2010 Apr; 16(2):141-5. PubMed ID: 19833629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
